A lot is being learned about the intersection between consuming marijuana and diabetes. Recently, a team of researchers has revealed that lots of people may be prone to developing diabetes after suffering from the severe forms of the COVID-19 disease. This complication can be alleviated using cannabis, the researchers think.
To confirm this theory, the researchers have set up a registry aimed at gathering data from doctors to establish how many people develop diabetes after suffering from severe COVID-19 and how many of those people had a history of using marijuana either recreationally or for medicinal purposes.
The CoviDiab Registry, as the researchers have called this research registry, is run by a team from the King’s College London in the UK.
They plan on building upon some earlier research which was completed towards the end of 2019. In that study, it was discovered that people who consumed marijuana had moderate blood glucose levels, an indicator that the person was less likely to develop diabetes. A similar study also found that the fasting insulin concentration in study subjects who consumed marijuana was lower than those who didn’t.
The King’s College London team is studying whether marijuana can increase the body’s ability to protect beta cells in the pancreas, thereby averting Type 1 diabetes which develops when the body is unable to make insulin.
The researchers also want to find out whether marijuana consumption accelerates the rate at which insulin production and sensitivity can resume after the ability of an individual’s body to process insulin has been compromised by severe COVID-19.
It is important at this point to emphasize that the link between marijuana use and COVID-19 is two-way. On the one hand, people who smoke marijuana are at a higher risk of contracting COVID-19 because smoke of any kind has an adverse effect on the lungs, thereby increasing your chances of suffering from severe forms of the COVID-19 disease.
On the other hand, marijuana use has been linked to improved metabolic function, a stronger immune system and a host of other therapeutic effects, all which put you in a good place to beat the COVID-19 disease should you ever contract it. The key here is in choosing your mode of marijuana administration carefully so that you get the benefits without exposing yourself to the risks. And above all, consult your doctor, especially when you are predisposed to developing diabetes. This message of caution resonates with what cannabis companies like Sugarmade, Inc. (OTCQB: SGMD) have been communicating to consumers, urging them to educate themselves before trying any cannabis product.
About CNW420
CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.
To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.CNW420.com
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer
Do you have questions or are you interested in working with CNW420? Ask our Editor
CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com
CNW420 is part of the InvestorBrandNetwork.
CannabisNewsWire 